Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × vorasidenib × 90 days × Clear all

Phase

Status

Sponsor Class

INDUSTRY 3 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Specimen Handling 39 Magnetic Resonance Spectroscopy 33 Cyclophosphamide 23 Radiation 20 Vincristine 19 Cisplatin 19 Carboplatin 17 Radiotherapy 15 Etoposide 15 Biopsy 14 Irinotecan 11 Doxorubicin 11 Dexamethasone 11 Methotrexate 10 Radiotherapy, Intensity-Modulated 9 Platinum 9 Leucovorin 9 Gemcitabine 9 Cytarabine 9 1,2-diaminocyclohexaneplatinum II citrate 9 fludarabine 8 Stem Cell Transplantation 8 Observation 8 Fluorouracil 8 merphos 7 dehydroftorafur 7 daratumumab 7 X-Rays 7 Surgical Procedures, Operative 7 Spinal Puncture 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06809322 2026-02-17

VIGOR

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Recruiting

Astrocytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡